June 05 , 2025
Advancing New Drug Marketing | PUMCH Department of Hematology Leads Clinical Trials for Novel Drug for Gaucher Disease
On May 15, 2025, velaglucerase beta for injection (CAN103), an innovative therapeutic drug for Gaucher disease developed through Phase I/II clinical t...